BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38477411)

  • 1. Nanoparticles Synergize Ferroptosis and Cuproptosis to Potentiate Cancer Immunotherapy.
    Li Y; Liu J; Chen Y; Weichselbaum RR; Lin W
    Adv Sci (Weinh); 2024 Jun; 11(23):e2310309. PubMed ID: 38477411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carrier-Free Self-Assembly Nano-Sonosensitizers for Sonodynamic-Amplified Cuproptosis-Ferroptosis in Glioblastoma Therapy.
    Zhu Y; Niu X; Ding C; Lin Y; Fang W; Yan L; Cheng J; Zou J; Tian Y; Huang W; Huang W; Pan Y; Wu T; Chen X; Kang D
    Adv Sci (Weinh); 2024 Jun; 11(23):e2402516. PubMed ID: 38582500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elesclomol-copper synergizes with imidazole ketone erastin by promoting cuproptosis and ferroptosis in myelodysplastic syndromes.
    Gao Y; Jin F; Zhang P; Zheng C; Zheng X; Xie J; Lu Y; Tong X; Du J; Zhang J; Wang Y
    Biomed Pharmacother; 2024 Jun; 175():116727. PubMed ID: 38733771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cuproptosis to Enhance Antitumor Immunotherapy.
    Lu X; Chen X; Lin C; Yi Y; Zhao S; Zhu B; Deng W; Wang X; Xie Z; Rao S; Ni Z; You T; Li L; Huang Y; Xue X; Yu Y; Sun W; Shen X
    Adv Sci (Weinh); 2024 May; 11(18):e2309984. PubMed ID: 38430531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer.
    Wang W; Lu K; Jiang X; Wei Q; Zhu L; Wang X; Jin H; Feng L
    J Exp Clin Cancer Res; 2023 Jun; 42(1):142. PubMed ID: 37277863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application.
    Liu N; Chen M
    Biomed Pharmacother; 2024 Feb; 171():116115. PubMed ID: 38181713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulus-Responsive Copper Complex Nanoparticles Induce Cuproptosis for Augmented Cancer Immunotherapy.
    Hu F; Huang J; Bing T; Mou W; Li D; Zhang H; Chen Y; Jin Q; Yu Y; Yang Z
    Adv Sci (Weinh); 2024 Apr; 11(13):e2309388. PubMed ID: 38269649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper-coordinated nanoassemblies based on photosensitizer-chemo prodrugs and checkpoint inhibitors for enhanced apoptosis-cuproptosis and immunotherapy.
    Liang W; Han C; Zhang D; Liu C; Zhu M; Xu F; Fang C; Zhang S; Liu C; Li Y
    Acta Biomater; 2024 Feb; 175():341-352. PubMed ID: 38122883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-Dose Anti-Angiogenic Therapy Sensitizes Breast Cancer to PD-1 Blockade.
    Li Q; Wang Y; Jia W; Deng H; Li G; Deng W; Chen J; Kim BYS; Jiang W; Liu Q; Liu J
    Clin Cancer Res; 2020 Apr; 26(7):1712-1724. PubMed ID: 31848190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered Microbial Nanohybrids for Tumor-Mediated NIR II Photothermal Enhanced Ferroptosis/Cuproptosis and Immunotherapy.
    Ruan Y; Zhuang H; Zeng X; Lin L; Wang X; Xue P; Xu S; Chen Q; Yan S; Huang W
    Adv Healthc Mater; 2024 Feb; 13(4):e2302537. PubMed ID: 37742322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting the compensatory elevation of xCT collaborates with disulfiram/copper-induced GSH consumption for cascade ferroptosis and cuproptosis.
    Zhang P; Zhou C; Ren X; Jing Q; Gao Y; Yang C; Shen Y; Zhou Y; Hu W; Jin F; Xu H; Yu L; Liu Y; Tong X; Li Y; Wang Y; Du J
    Redox Biol; 2024 Feb; 69():103007. PubMed ID: 38150993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD-L1 for Enhanced Cancer Immunotherapy.
    Guo B; Yang F; Zhang L; Zhao Q; Wang W; Yin L; Chen D; Wang M; Han S; Xiao H; Xing N
    Adv Mater; 2023 Jun; 35(22):e2212267. PubMed ID: 36916030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A biomimetic cuproptosis amplifier for targeted NIR-II fluorescence/photoacoustic imaging-guided synergistic NIR-II photothermal immunotherapy.
    Dai Y; Zhu L; Li X; Zhang F; Chen K; Jiao G; Liu Y; Yang Z; Guo Z; Zhang B; Shen Q; Zhao Q
    Biomaterials; 2024 Mar; 305():122455. PubMed ID: 38160626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-mode Rhein-based nano-platform synergizing ferrotherapy/chemotherapy-induced immunotherapy for enhanced tumor therapy.
    Zhu X; Xie L; Tian J; Jiang Y; Song E; Song Y
    Acta Biomater; 2024 May; 180():383-393. PubMed ID: 38570106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme Core Spherical Nucleic Acid That Enables Enhanced Cuproptosis and Antitumor Immune Response through Alleviating Tumor Hypoxia.
    Huang Y; Liu X; Zhu J; Chen Z; Yu L; Huang X; Dong C; Li J; Zhou H; Yang Y; Tan W
    J Am Chem Soc; 2024 May; 146(20):13805-13816. PubMed ID: 38552185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Enzyme-Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis-Based Synergistic Cancer Therapy.
    Xu Y; Liu SY; Zeng L; Ma H; Zhang Y; Yang H; Liu Y; Fang S; Zhao J; Xu Y; Ashby CR; He Y; Dai Z; Pan Y
    Adv Mater; 2022 Oct; 34(43):e2204733. PubMed ID: 36054475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendrimer/metal-phenolic nanocomplexes encapsulating CuO
    Huang H; Guo H; Liu J; Ni C; Xia L; Cao X; Xia J; Shi X; Guo R
    Acta Biomater; 2024 May; ():. PubMed ID: 38801869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhalable metal-organic framework-mediated cuproptosis combined with PD-L1 checkpoint blockade for lung metastasis synergistic immunotherapy.
    Yan C; Liu Y; Zhao G; Yang H; Lv H; Li G; Li Y; Fu Y; Sun F; Feng Y; Li Y; Zhao Z
    Acta Pharm Sin B; 2024 May; 14(5):2281-2297. PubMed ID: 38799628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal Clearable Ultrasmall Single-Crystal Fe Nanoparticles for Highly Selective and Effective Ferroptosis Therapy and Immunotherapy.
    Liang H; Wu X; Zhao G; Feng K; Ni K; Sun X
    J Am Chem Soc; 2021 Sep; 143(38):15812-15823. PubMed ID: 34473493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Self-Amplifying ROS-Responsive Nanoplatform for Simultaneous Cuproptosis and Cancer Immunotherapy.
    Wu H; Zhang Z; Cao Y; Hu Y; Li Y; Zhang L; Cao X; Wen H; Zhang Y; Lv H; Jin X
    Adv Sci (Weinh); 2024 Jun; 11(23):e2401047. PubMed ID: 38569217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.